9 Jan 2014

UCB Credit Facility Renewed with Improved Terms

Read More
2 Jan 2014

Romosozumab phase 2 data published in New England Journal of Medicine show significant increases in bone mineral density at both spine and hip

Read More
10 Dec 2013

Acquisition of own shares

Read More
20 Nov 2013

New data from UCB’s epilepsy portfolio to be highlighted at the 67th Annual Meeting of the American Epilepsy Society

Read More
4 Nov 2013

UCB files VIMPAT® (lacosamide) in the US as monotherapy treatment in adult epilepsy patients with partial-onset seizures

Read More
25 Oct 2013

UCB receives CHMP positive opinion for Cimzia® (certolizumab pegol) in active psoriatic arthritis

Read More
25 Oct 2013

UCB Interim Report for the first nine months of 2013:

Read More
18 Oct 2013

Cimzia® (certolizumab pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis

Read More
4 Oct 2013

UCB announces scientific presentations on romosozumab at the annual meeting of the American Society for Bone and Mineral Research 2013

Read More
30 Sep 2013

Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis

Read More
Subscribe to